Researchers in Korea found that those who were taking sodium-glucose cotransporter-2 (SGLT-2) inhibitors to treat diabetes slashed the risk of dementia by up to half. Researchers in Korea found that those who were taking sodium-glucose cotransporter-2 (SGLT-2) inhibitors to treat diabetes slashed the risk of dementia by up to half.
Type 2 diabetes drug could cut the risk of getting dementia, study finds
